Prophylaxis for Heterotopic Ossification Following Distal Biceps Tendon Repair

医学 异位骨化 外科 肘部 并发症 肱二头肌 肌腱 骨科手术
作者
Christopher L. Antonacci,Symone M. Brown,Michael J. O’Brien,Mary K. Mulcahey
出处
期刊:Orthopedics [SLACK, Inc.]
卷期号:44 (4) 被引量:7
标识
DOI:10.3928/01477447-20210618-22
摘要

Heterotopic ossification (HO) is a possible complication of distal biceps tendon repair (DBTR). Several agents can prevent HO formation, although relatively few studies have investigated prophylaxis specifically after DBTR. The purposes of this study were to survey members of the American Shoulder and Elbow Surgeons (ASES) to determine (1) what percentage use HO prophylaxis after DBTR; (2) type, dosage, and duration of prophylaxis used; and (3) use of single-incision or double-incision surgical technique. An anonymous electronic survey was distributed to ASES members to determine the use of HO prophylaxis and DBTR technique. The survey included questions regarding the number of DBTRs performed annually; preferred surgical technique and implants; and type, dosage, and duration of HO prophylaxis used before, during, and after surgery. Descriptive statistics were used to analyze the results. Of 173 respondents, 98 (56.6%) performed 1 to 10 DBTRs per year, 65 (37.6%) performed 11 to 25 DBTRs per year, and 10 (5.8%) performed 26 to 50 DBTRs per year. A total of 131 (75.7%) preferred the single-incision technique, whereas 42 (24.3%) preferred the double-incision technique. A total of 94 (54.3%) performed DBTR using a metal button and interference screw, 35 (20.2%) through drill holes, 25 (14.5%) with suture anchors, and 19 (11.0%) with a metal button alone. A total of 132 (76.3%) respondents did not use HO prophylaxis, and 41 (23.7%) used nonsteroidal anti-inflammatory drugs following surgery. A total of 35 (85.4%) used indomethacin, 18 (51.4%) of whom preferred 75 mg/d for 3 to 4 weeks. Heterotopic ossification is a commonly reported complication following DBTR, especially with the double-incision technique. Prophylaxis with anti-inflammatory medications and suppressive modalities (radiation therapy) appear to reduce the incidence of HO. Despite these data, most surgeons (76.3%) do not use HO prophylaxis. Low annual volume of cases, lack of large-volume studies with outcome data, and the dominant use of the single-incision repair technique may explain this. [ Orthopedics . 2021;44(4):e588–e592.]
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
充电宝应助科研通管家采纳,获得10
2秒前
2秒前
ding应助科研通管家采纳,获得10
2秒前
2秒前
Lucas应助科研通管家采纳,获得10
2秒前
大模型应助科研通管家采纳,获得10
2秒前
直率千愁应助科研通管家采纳,获得20
3秒前
3秒前
3秒前
犹豫的归尘完成签到,获得积分10
4秒前
研友_VZG7GZ应助YFW采纳,获得10
4秒前
怡然行天完成签到,获得积分10
8秒前
CodeCraft应助Lee采纳,获得10
9秒前
11秒前
吴兰田完成签到,获得积分10
12秒前
下文献的蜉蝣完成签到 ,获得积分10
14秒前
15秒前
天真无招发布了新的文献求助10
15秒前
16秒前
吴兰田发布了新的文献求助20
18秒前
徐佳达完成签到,获得积分10
18秒前
18秒前
20秒前
书童发布了新的文献求助10
21秒前
2024论文计划完成签到,获得积分20
22秒前
风趣的芝麻完成签到 ,获得积分10
26秒前
Jasper应助334niubi666采纳,获得10
26秒前
迅速灵竹发布了新的文献求助10
27秒前
Kris完成签到,获得积分10
27秒前
天真无招完成签到,获得积分10
28秒前
南柯完成签到,获得积分10
33秒前
sby19完成签到 ,获得积分10
33秒前
36秒前
aertom完成签到,获得积分10
36秒前
科研1发布了新的文献求助10
36秒前
37秒前
Kaelyn发布了新的文献求助10
37秒前
陈嘻嘻嘻嘻完成签到,获得积分10
38秒前
334niubi666发布了新的文献求助10
39秒前
39秒前
高分求助中
Licensing Deals in Pharmaceuticals 2019-2024 3000
Cognitive Paradigms in Knowledge Organisation 2000
Effect of reactor temperature on FCC yield 2000
Near Infrared Spectra of Origin-defined and Real-world Textiles (NIR-SORT): A spectroscopic and materials characterization dataset for known provenance and post-consumer fabrics 610
Introduction to Spectroscopic Ellipsometry of Thin Film Materials Instrumentation, Data Analysis, and Applications 600
Promoting women's entrepreneurship in developing countries: the case of the world's largest women-owned community-based enterprise 500
Shining Light on the Dark Side of Personality 400
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3308460
求助须知:如何正确求助?哪些是违规求助? 2941800
关于积分的说明 8505877
捐赠科研通 2616792
什么是DOI,文献DOI怎么找? 1429755
科研通“疑难数据库(出版商)”最低求助积分说明 663888
邀请新用户注册赠送积分活动 648999